MENU

Clinical Controversies in Vitamin D Testing and Treatment

Sponsored by: DiaSorin
Speaker
  • Senior Consultant, Minnesota Personalized Medicine
    Biography
      Gregory A. Plotnikoff, MD, MTS, FACP, is a board-certified internist and pediatrician in active clinical practice who has received numerous national and international awards for research and education. He is the lead author of one book, 25 textbook chapters and more than 60 articles in the peer-reviewed medical literature. His 2003 article on vitamin D deficiency and chronic, non-specific musculoskeletal pain is one of the most highly-cited articles in the history of the Mayo Clinic Proceedings. He is a graduate of Carleton College, Harvard University Divinity School and the University of Minnesota Medical School.

    Abstract

    Clinical Controversies Recently, both national and international authorities have promulgated conflicting statements on vitamin D testing and treatment. What are clinicians and patients to do?

    This webinar will address the existing data so that participants can answer these five key clinical questions:

    • Who might be at risk for low vitamin D? 
    • Can we assess for vitamin D deficiency by physical exam? 
    • Is a multivitamin or prenatal vitamin sufficient?
    • What are the best means to assure sufficient vitamin D levels?
    • What research questions still need to be answered?
    • Sufficient time will be available for a live question and answer period for all real-time participants.

    Learning Objectives:

    1) Understand the role of vitamin D as a hormone
    2) Identify which patients are at greatest risk for low vitamin D
    3) Recognize the clinical indications for vitamin D testing and treatment
     
     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 05, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 05, 2020 7:00 AM PST
    DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
    Loading Comments...
    Show Resources
    Attendees
    • See more